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Abstract
Background: Brown adipose tissue (BAT) has thermogenic potential. For its activation, cold exposure is considered
a critical factor though other determinants have also been reported. The purpose of this study was to assess the
relationship between neoplastic status and BAT activity by 2-deoxy-2-[18F]fluoro-D-glucose (
18F-FDG) positron
emission tomography/computed tomography (PET/CT) in people living in the tropics, where the influence of
outdoor temperature was low.
Methods:
18F-FDG PET/CT scans were reviewed and the total metabolic activity (TMA) of identified activated BAT
quantified. The distribution and TMA of activated BAT were compared between patients with and without a cancer
history. The neoplastic status of patients was scored according to their cancer history and
18F-FDG PET/CT findings.
We evaluated the relationships between the TMA of BAT and neoplastic status along with other factors: age, body
mass index, fasting blood sugar, gender, and outdoor temperature.
Results: Thirty of 1740 patients had activated BAT. Those with a cancer history had wider BAT distribution (p =
0.043) and a higher TMA (p = 0.028) than those without. A higher neoplastic status score was associated with a
higher average TMA. Multivariate analyses showed that neoplastic status was the only factor significantly associated
with the TMA of activated BAT (p = 0.016).
Conclusions: Neoplastic status is a critical determinant of BAT activity in patients living in the tropics. More active
neoplastic status was associated with more vigorous TMA of BAT.
Keywords: Neoplastic status, BAT,
18F-FDG PET
Background
Brown adipose tissue (BAT) is a highly specialized ther-
mogenic tissue that is essential for non-shivering ther-
mogenesis [1]. BAT activation helps maintain normal
body temperatures in newborns. Although the amount
of BAT declines with age, islets of brown adipocytes
remain in the white adipose tissue of adult humans
[1,2]. High levels of BAT in the adult body are asso-
ciated with cancer-induced cachexia and may reflect an
abnormal mechanism responsible for substantial energy
expenditure and subsequent weight loss [3]. BAT has
recently attracted attention because it consumes stored
energy and may thereby be involved in human obesity
and age-related metabolic diseases [4,5]. The two
extremes in the regulation of body weight, obesity and
cachexia can be considered two sides of the same coin
[6,7]. Beyond the well-known influence of outdoor tem-
perature on activated BAT, little has been published on
t h ei m p a c to fn e o p l a s t i cs t a t u s .W ed i dt h i ss t u d yt o
evaluate the relationship between BAT activity and neo-
plastic status by 2-deoxy-2-[18F]fluoro-D-glucose (
18F-
FDG) positron emission tomography/computed tomo-
graphy (PET/CT) in people living in the tropics, where
the influence of outdoor temperature is low. * Correspondence: ntchiu@mail.ncku.edu.tw
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Patients
Between June 2005 and May 2009, 1740 patients at our
institution (located at 22.7°N) underwent 1903 consecu-
tive clinical
18F-FDG PET/CT scans for a variety of pur-
poses; these scans were reviewed for analysis. This
retrospective study was approved by our hospital’sI n s t i -
tutional Review Board with a waiver of consent.
18F-FDG PET/CT
18F-FDG PET/CT has been successfully used to diagnose
various cancers and inflammatory processes [8] as well
as to visualize functional activated BAT [9-13] based on
the presence of uncoupling protein 1 (UCP1)-positive
adipocytes with multilobulated lipid droplets [14]. To
identify activated BAT, we used an in-line PET/CT sys-
tem that could clearly localize the
18F-FDG uptake to fat
tissue and exclude muscle and lymph nodes. To esti-
mate the total metabolic activity (TMA) of BAT, we
used three-dimensional (3D) voxel-based analysis rather
than the two-dimensional (2D) region of interest
method, taking both volume and
18F-FDG intensity into
consideration, which is an accurate method for quantify-
ing activated BAT in the living human body.
PET/CT scans were done using a combined PET/CT
scanner (Discovery ST; GE Healthcare, Waukesha, WI,
USA). The patients fasted for at least 6 hours before the
18F-FDG injection. No attempt was made to prevent BAT
activation before the PET/CT scan by prescribing any
medication such as beta-blockers or diazepam. The
patients were injected with 370-555 MBq of
18F-FDG and
the dose were adjusted according to body weight in pedia-
tric patients. Then, they remained recumbent in an iso-
lated, continually air-conditioned and dimly lit room for 1
hour. CT images were acquired first without contrast
medium using the following parameters: 140 kV, 170 mA
(maximum), and 3.75-mm thick sections for attenuation
correction and the later imaging fusion. PET scans were
then taken from the mid-thigh to skull with 5-7 bed posi-
tions of 5 minutes each. The transaxial PET data were
reconstructed as 128 × 128-pixel images with a slice thick-
ness of 3.27 mm, a spatial resolution of 6.2-6.9 mm full
width at half-maximum (FWHM), and an axial resolution
of 4.6-6.1 mm FWHM by applying an ordered subsets
expectation maximization algorithm (OSEM, 2 iterations,
30 subsets). Coronal, and sagittal sections, as well as maxi-
mum intensity projection PET images, were also refor-
matted for PET/CT imaging fusion and interpretation.
Identifying brown adipose tissue and measuring its total
metabolic activity
18F-FDG PET/CT scans with reports stating that the
patients had activated BAT were reviewed again by two
experienced nuclear medicine physicians to confirm the
presence of activated BAT and identify its anatomical
distribution. Activated BAT was considered present if
there were areas of
18F-FDG uptake corresponding to
the CT density of adipose tissue (-250 to -50 Hounsfield
units) that were distinguishable from nearby tissue by
distinct patterns consistent with BAT [11,15]. The ana-
tomical distribution of increased
18F-FDG uptake corre-
sponding to BAT on fused PET/CT images was
classified as being in the posterior neck (PN), supraclavi-
cular (SC) including mediastinal extension, paravertebral
(PV), or suprarenal (SR) regions (Figure 1). The distri-
bution of activated BAT, age, body mass index (BMI),
fasting blood sugar, and gender of patients with acti-
vated BAT were recorded.
For 3D voxel-based analysis, the volume and
18F-FDG
uptake of each activated BAT deposit were measured
using OsiriX 64-bit software (version 3.7.1; Antoine Ros-
set; http://www.osirix-viewer.com/index.html) run on a
Macintosh OS × platform. The standardized uptake
value (SUV) within the region of interest was calculated
semi-quantitatively according to the formula:
SUV = measured activity

MBq/mL

/

injected does of
18F-F D G(MBq)/body weight

g

The seeded region growing method with the lower
bound set initially at an SUV of 2.5 was used to deter-
mine the volume of interest (VOI) of the activated BAT.
The analysis required agreement between the two physi-
cians, and the results confirmed by the fused CT images.
A maximum adjustment of 0.5 for the lower bound of
Figure 1 18F-FDG PET/CT scan of a 33-year-old woman with a
history of cervical cancer treated with a radical hysterectomy:
(A) maximum intensity projection, (B) coronal PET, and (C)
coronal PET/CT fusion images showing activated BAT deposits
in the posterior neck (PN), supraclavicular (SC), paravertebral
(PV) and suprarenal (SR) areas. The hypermetabolic foci in the
pelvis were locally recurrent tumors (red arrows) and the neoplastic
status score was 3. (D) We used OsiriX 64-bit software with the
seeded region growing method (green zone) to obtain the volume
of interest (VOI) of activated BAT from the PET images. (E) Color
image segmentation based on 3-dimensional clustering was used
for display and volume computation. Total metabolic activity (TMA)
was defined as the summation of the volume × standardized
uptake value (SUV) within the VOIs of the activated BAT deposits.
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adjust for the effects of unsatisfactory contrast between
the BAT and background activity (Figures 1D and 1E).
The TMA was defined as the summation of the volume
× SUV within the VOIs of each patient’s total activated
BAT deposits. Only the first PET/CT study of each
patient was included for analysis of continuous variables.
Determining neoplastic status
The neoplastic status of patients with activated BAT was
scored according to their cancer history and
18F-FDG
PET/CT findings as follows: 0, patients who underwent
PET/CT for cancer screening without a history of can-
cer and had negative findings on the PET/CT scan; 1,
patients who had a history of cancer but had negative
findings on the PET/CT scan; 2, patients with a history
of cancer and on the PET/CT scan had abnormal
uptake probably related to inflammation or malignancy
but who were lost to follow-up before cancer could be
confirmed by pathology or additional imaging studies;
and 3, patients who on the PET/CT scan had pathologi-
cal uptake because of cancer confirmed by pathology or
follow-up imaging.
Outdoor temperature parameters
For our patients with activated BAT, the daily average
outdoor temperatures in °C for the date of the PET
study (TPET) and the 7 days prior (T1-7) were recorded.
The 1-day temperature difference (TPET -T 1), mean
daily average temperature [mean T = (TPET +T 1 +...
T7)/8], and maximum continuous temperature decrease
within the 7 days before the PET study (maxΔT) in °C
were calculated. The temperature descent grade (DG =
maxΔT/mean T) and descent rate (DR = maxΔT/days
of continuous temperature descent) were also calculated.
T h eo u t d o o rd a i l ya v e r a g et e m p e r a t u r ed a t aw e r e
obtained from the Central Weather Bureau of Taiwan.
Statistical analysis
Continuous variables are means ± standard error (SE).
Kolmogorov-Smirnov statistics were used to test the
data sets for normal distribution. Student’s t-test was
used in group comparisons of normally distributed data,
and the Mann-Whitney U-test was used for non-nor-
mally distributed data. Categorical variables were ana-
lyzed using the c
2 test. For patients with activated BAT,
univariate analyses consisted of Pearson’s correlations,
Spearman’s rank correlation, and Mann-Whitney U-test
of the associations between the TMA of BAT and biolo-
gical and environmental factors of age, BMI, fasting
blood sugar, gender, and outdoor temperature para-
meters. The TMA of BAT in the 4 different neoplastic
status categories was analyzed using the Jonckheere-
Terpstra test for ordered alternatives, a nonparametric
test for trends. Multiple linear regression analysis was
used to test the significance of the associations between
the TMA of BAT and the biological and environmental
factors. SPSS 17 for Windows (SPSS Inc., Chicago, IL,
USA) was used for all statistical analysis. Significance
was set at p < 0.05.
Results
Thirty (26 females and 4 males; age range: 12-73 years
old; mean age: 40.6 ± 2.7 years old) of the 1740 patients
had activated BAT, which was identified on 37 scans.
The demographic features of the patients are summar-
ized in Table 1. There were 1,171 patients with a history
of cancer and were given an
18F-FDG PET/CT scan to
evaluate the disease. The other 569 patients without a
history of cancer requested an
18F-FDG PET/CT scan
for a cancer survey. The prevalence of activated BAT in
the two groups was not significantly different: 1.79% and
1.58%, respectively. However, patients with activated
BAT were significantly younger, leaner, more often
female, had lower fasting blood sugar, and underwent
an
18F-FDG PET/CT scan during lower outdoor tem-
perature conditions than did the patients without acti-
vated BAT.
Most activated BAT was found in the supraclavicular
area, and the least was found in the suprarenal area.
Activated BAT was found in only one distribution
region in 8 patients, 2 regions in 7 patients, 3 regions in
12 patients, and 4 regions in 3 patients. The imaging
and demographic characteristics of patients with
Table 1 Demographic features of patients with and without activated BAT detected using
18F-FDG PET/CT
Characteristic With activated BAT
(n = 30)
Without activated BAT
(n = 1710)
p-value
Age (y) 40.6 ± 2.7 (12-73) 53.8 ± 0.3 (1-86) < 0.001*
BMI (kg/m
2) 21.5 ± 0.6 (16.4-32.9) 24.0 ± 0.1 (13.0-40.6) < 0.001*
Fasting blood sugar (mg/dL) 83.6 ± 1.8 (56-104) 91.4 ± 0.4 (52-192) 0.032*
Gender (female:male) 26:4 697:1013 < 0.001
†
Outdoor temperature (°C) 23.0 ± 0.7(16.7-29.6) 25.3 ± 0.1 (14.2-31.5) 0.001
‡
Cancer: Non-cancer 21:9 1150: 560 0.750
†
Data are means ± standard error and (range).
*Student’s t-test;
†c
2 test;
‡Mann-Whitney U-test.
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18F-FDG PET/CT are summarized in
Tables 2 and 3. The distribution of activated BAT was
significant wider in patients with a history of cancer
than without (p = 0.043). The TMA of activated BAT
was higher in patients with a history of cancer than
without (p = 0.028). A higher neoplastic status score
was associated with a higher average TMA of BAT
(Jonckheere-Terpstra Trend Test across the 4 groups, p
= 0.043), although there was a positive but non-signifi-
cant association between neoplastic status and the distri-
bution of BAT (p = 0.148) (Figure 2). In univariate
analysis, no significant association was found between
the TMA of BAT and age, BMI, fasting blood sugar,
gender, or outdoor temperature parameters. Only the
neoplastic status was significantly associated with the
TMA of BAT. A multiple linear regression analysis
showed that neoplastic status remained the only signifi-
cant determinant of the TMA of BAT (p = 0.016)
(Table 4). We also found one patient with repeated
18F-
FDG PET scans who showed lower BAT metabolic
activity after surgical excision of his malignancy (Figure
3).
Discussion
To explore the relationship between BAT activity and
neoplastic status, we used
18F-FDG PET/CT to deter-
mine the distribution and TMA of activated BAT in our
patients living in the tropics, where the influence of out-
door temperature was low and the effect of neoplastic
status on the activation of BAT could be more clearly
determined. We found that neoplastic status was a criti-
cal determinant of BAT activity.
In limited numbers of patients, a high prevalence of
activated BAT has been reported in patients with lym-
phoma (17%) and in female patients with breast cancer
(80%) [16,17]. Light-microscopic examination of
necropsy specimens of periadrenal tissue has shown that
t h ep r e v a l e n c eo fB A Ti sh i g h e ri np a t i e n t sw i t hc a n c e r
cachexia (80%) than in age-matched controls [3]. More-
over, animal studies have shown that cancer cachexia
due to an increased metabolic rate may be mediated by
sympathetic stimulation and subsequent BAT thermo-
genesis with overexpression of UCP1 [18,19]. Cancer
patients have very high chronic stress responses caused
by psychosocial distress [20,21]. The biological conse-
quences of cumulative stress include catecholamine
hyperactivity of the sympathetic nervous system (SNS)
r e s p o n s e[ 2 2 ] ,a n dt h eS N Sp l a y sak e yr o l ei nt h ea c t i -
vation of BAT. Our study, which reduced the interfer-
ence of low outdoor temperature, further demonstrates
that more active neoplastic status was associated with
more vigorous TMA of BAT.
Our patients with neoplastic status scores of 2 were
thought to have either malignancies, inflammatory
lesions, or a combination of the two. We hypothesize
that inflammation also strongly influences the metabolic
activity of BAT in our patients with activated BAT.
Inflammatory stimulated pain and stress can activate the
fight-or-flight response with subsequent increases in
adrenaline and noradrenaline. Lechin et al. [23] reported
significant increases in plasma catecholamines in various
patient groups during periods of disease exacerbation.
The hypothalamic-pituitary-adrenal (HPA) axis and
autonomic nervous system are both activated during
inflammation as an elaborate multi-directional commu-
nication pathway designed to restore homeostasis, in
part by regulating the inflammatory and subsequent
immune responses. Efferent signals are relayed to the
site(s) of inflammation primarily by the secretion of nor-
epinephrine from efferent sympathetic neurons and of
epinephrine from the adrenal medulla [24]. On the
o t h e rh a n d ,t u m o rn e c r o s i sf a c t o ra l p h a( T N F - a,
cachectin), a potential mediator of cancer cachexia and
the dysregulation of inflammation, increases the thermo-
genic activity of BAT and the rate of fatty acid synthesis
from glucose in BAT assayed in vitro [25,26]. These
processes provide a reasonable explanation for the asso-
ciation between neoplastic status/inflammation and BAT
metabolic activity.
Several factors may affect the activation of BAT. The
conversion of white to brown adipocytes can be induced
by b-adrenergic stimulation with hormones (catechola-
mines) that are released in response to stress or low
blood sugar [27]. Activated BAT is not present in rele-
vant quantities in adults except during sympathetic sti-
mulation. Physical and chemical stressors, e.g., cold,
h e a t ,r a d i a t i o n ,n o i s e ,v i b r a tion, pain, immobilization,
and psychological stress, can cause SNS responses [28].
In addition, an in vivo animal study [29] reported stress
from burn injuries and cutaneous wounds were
Table 2 Imaging characteristics of activated BAT on
18F-
FDG PET/CT
Characteristic n Measured value
Anatomical distribution
Posterior neck (SUVmax) 21 3.5 ± 0.3 (1.6-6.6)
Supraclavicular (SUVmax) 29 5.0 ± 0.5 (1.8-9.5)
Paravertebral (SUVmax) 17 4.4 ± 0.5 (2.0-8.1)
Suprarenal (SUVmax) 3 5.8 ± 0.7 (4.8-7.2)
BAT total metabolic volume (cm
3) 32.1 ± 7.5 (0.1-143.5)
BAT total metabolic activity 95.9 ± 24.1 (0.2-467.5)
1 distribution region 8 4.7 ± 4.2 (0.2-34.4)
2 distribution regions 7 46.9 ± 20.0 (0.2-137.2)
3 distribution regions 12 131.0 ± 35.9 (13.2-423.7)
4 distribution regions 3 312.5 ± 114.4 (89.3-467.5)
Data are means ± standard error and (range).
SUVmax : maximum standardized uptake value
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18F-FDG accumulation
in BAT. BAT activity can be directly inhibited by beta-
blockers such as propranolol, and partially reduced by
diazepam, the latter probably because anxiety may also
activate the SNS [30]. BAT activation has been reported
to be more frequent during the cooler seasons of the
year; however, the metabolic activity of BAT depends on
many factors [13,31]. Consistent with previous studies
[9,11-13], our patients with activated BAT were
significantly younger, leaner, more often female, had
lower fasting blood sugar, and underwent
18F-FDG
PET/CT during colder outdoor temperature conditions
than patients without activated BAT. Although outdoor
temperature was related to the prevalence of BAT, none
of the outdoor temperature parameters investigated in
our study was significantly associated with the TMA of
BAT. Few studies have explored the relationship
between BAT activity and outdoor temperature. Consis-
tent with our results, Kim et al. [10] found no significant
relationship between the intensity of BAT
18F-FDG
uptake and daily average outdoor temperature. A study
[13] done in Quebec, Canada, where the average out-
door temperature is substantially lower than in the tro-
pics, showed that lower outdoor temperature was
associated with an increase in the metabolic activity of
Table 3 Univariate analysis of relationships between the total metabolic activity (TMA) of BAT and various biological
and environmental factors (N = 30)
Factor TMA Correlation coefficient p-value
NEOPLASTIC STATUS SCORE 0.043*
0 (n = 9) 28.6 ± 13.2 (0.2-91.3)
1 (n = 5) 92.0 ± 47.4 (4.6-209.2)
2 (n = 8) 110.0 ± 52.7 (0.3-467.5)
3 (n = 8) 159.8 ± 62.2 (0.2-423.7)
Age (y) 0.084 0.658
†
BMI (kg/m
2) 0.033 0.861
†
Fasting blood sugar (mg/dL) 0.112 0.554
†
GENDER 0.428
‡
Male (n = 4) 149.0 ± 96.1 (0.2-423.7)
Female (n = 26) 87.7 ± 24.2 (0.2-467.5)
OUTDOOR TEMPERATURE PARAMETERS (°C)
Outdoor temperature (TPET) 0.101 0.596
§
MaxΔT -0.297 0.110
§
One-day temperature decline (TPET -T 1) 0.171 0.366
§
Mean T: (TPET +T 1 +... T7)/8 0.087 0.649
§
Decline grade (maxΔT/mean T) -0.254 0.181
§
Decline rate (maxΔT/duration) -0.319 0.086
§
Data are means ± standard error and (range).
*Jonckheere-Terpstra test;
†Pearson’s correlation;
‡Mann-Whitney U-test;
§Spearman’s rank correlation.
Figure 2 The association between BAT activity and neoplastic
status. (A) BAT distribution regions and (B) total metabolic activity
(TMA) of the BAT deposits in patients with different neoplastic
status. The distribution of activated BAT was significantly (p = 0.043)
wider in patients with a history of cancer than in those without. The
TMA of activated BAT was significantly (p = 0.028) higher in patients
with a history of cancer than in those without. A higher neoplastic
status score was associated with a higher average TMA of BAT
(Jonckheere-Terpstra Trend Test across the 4 groups, p = 0.043),
although there was a positive but non-significant association
between neoplastic status and distribution of BAT (p = 0.148). Error
bars indicate standard error of the mean.
Table 4 Multiple linear regression analysis of the
relationships between total metabolic activity (TMA) of
BAT and various biological and environmental factors (N
= 30)
Factor Coefficient Standard error p-value
Neoplastic status 51.377 19.686 0.016*
Age 3.304 1.842 0.086
BMI (kg/m
2) -10.508 9.392 0.275
Fasting blood sugar (mg/dL) 0.149 2.251 0.948
Gender (male) 135.308 102.922 0.202
Outdoor temperature TPET (°C) 10.178 5.903 0.098
* Statistically significant.
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related to how low the outdoor temperature was.
Unlike patients in previous studies done in temperate
zones, our patients were in tropical areas. The consis-
tently warm outdoor temperature reduces the stimulat-
ing effects of cold environmental temperature on BAT.
Univariate and multivariate analyses showed that neo-
plastic status was the only factor significantly associated
with the TMA of activated BAT. We hypothesize that
low environmental temperature is an initiator of BAT
activation, and neoplastic status is important in the
quantified metabolic activity of those activated BAT
deposits: it is a promoter. Although we cannot conclude
f r o mt h ed a t ap r e s e n t e dt h a tt h ep r e s e n c eo fd e m o n -
strable activated BAT is a sign of cancer or the reactiva-
tion of cancer, future research on the occurrence of
activated BAT and neoplastic status may be warranted.
The current study has several limitations. Because this
study was retrospective, indices of the stresses associated
with cancer, i.e., measurements of the HPA or SNS
activities and other psychological or non-psychological
factors that could influence catecholamine levels, were
not well assessed. In addition, the number of patients
for the analysis of the associations between the TMA of
BAT and biological and environmental factors was rela-
t i v e l ys m a l l .Al a r g e rn u m b e ro fp a t i e n t sw i l lb en e e d e d
for verification.
Conclusions
In patients with activated BAT, neoplastic status is a cri-
tical determinant of BAT activity. A more active neo-
plastic status was associated with more vigorous BAT
metabolic activity.
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